Synthorx's Series B Round

Synthorx raised a round of funding on July 20, 2016.

Synthorx leverages a genetic alphabet platform that expands the chemical and structural repertoire of protein therapeutics and uncovers new ways to modulate pharmacological properties of biologics. Th…

Articles about Synthorx's Series B Round: